We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$79.2B
AUM Growth
+$3.07B
(+4%)
Cap. Flow
-$2.3B
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
48.93%
Holding
809
New
117
Increased
205
Reduced
335
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$331M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$327M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$319M |
| 4 |
Allison Transmission
ALSN
|
+$195M |
| 5 |
BA.PRA
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
|
+$50M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$853M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$294M |
| 3 |
NVIDIA
NVDA
|
+$266M |
| 4 |
Netflix
NFLX
|
+$190M |
| 5 |
Meta Platforms (Facebook)
META
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.48% |
| 2 | Consumer Discretionary | 18.83% |
| 3 | Communication Services | 18.1% |
| 4 | Healthcare | 11.79% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Cigna
CI
$74.3B
| $62K | ﹤0.01% |
225
-21
| -9% | -$6.69K |
|
577
Palo Alto Networks
PANW
$310B
| $62K | ﹤0.01% |
338
+196
| +138% | +$37K |
|
578
PACCAR
PCAR
$70B
| $62K | ﹤0.01% |
+597
| New | +$65.3K |
|
579
Allstate
ALL
$68.5B
| $61K | ﹤0.01% |
+318
| New | +$61.7K |
|
580
Prudential Financial
PRU
$42.1B
| $61K | ﹤0.01% |
+514
| New | +$63.5K |
|
581
Analog Devices
ADI
$188B
| $60K | ﹤0.01% |
281
+30
| +12% | +$6.63K |
|
582
Gilead Sciences
GILD
$166B
| $60K | ﹤0.01% |
652
-22
| -3% | -$1.98K |
|
583
Johnson Controls International
JCI
$92.1B
| $60K | ﹤0.01% |
765
-216
| -22% | -$17.3K |
|
584
Keurig Dr Pepper
KDP
$39.6B
| $60K | ﹤0.01% |
1,857
-21
| -1% | -$711 |
|
585
Coinbase
COIN
$39.4B
| $59K | ﹤0.01% |
+238
| New | +$60.4K |
|
586
Intercontinental Exchange
ICE
$85.2B
| $59K | ﹤0.01% |
+399
| New | +$63.2K |
|
587
iShares US Technology ETF
IYW
$25.4B
| $59K | ﹤0.01% |
369
| – | – |
|
|
HOLX
588
DELISTED
Hologic
HOLX
| $58K | ﹤0.01% |
808
| – | – |
|
589
Norfolk Southern
NSC
$75.4B
| $58K | ﹤0.01% |
248
-310
| -56% | -$78.8K |
|
590
Phillips 66
PSX
$84.5B
| $58K | ﹤0.01% |
511
-61
| -11% | -$7.76K |
|
591
Invesco QQQ Trust
QQQ
$481B
| $58K | ﹤0.01% |
113
| – | – |
|
592
Becton Dickinson
BDX
$48.6B
| $57K | ﹤0.01% |
253
+87
| +52% | +$20.1K |
|
593
EOG Resources
EOG
$73.6B
| $57K | ﹤0.01% |
463
+97
| +27% | +$12.4K |
|
594
Eversource Energy
ES
$26.9B
| $57K | ﹤0.01% |
+993
| New | +$61.9K |
|
595
Stryker
SYK
$131B
| $57K | ﹤0.01% |
159
-27
| -15% | -$10K |
|
596
Cognizant
CTSH
$25.9B
| $56K | ﹤0.01% |
+734
| New | +$57.4K |
|
597
Omega Healthcare
OHI
$14.4B
| $56K | ﹤0.01% |
1,475
+319
| +28% | +$12.7K |
|
598
State Street Technology Select Sector SPDR ETF
XLK
$123B
| $56K | ﹤0.01% |
484
| – | – |
|
599
Chubb
CB
$135B
| $55K | ﹤0.01% |
+200
| New | +$56.8K |
|
600
LyondellBasell Industries
LYB
$19.8B
| $55K | ﹤0.01% |
742
-622
| -46% | -$52.3K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q4 2024 Portfolio in Review
As of Q4 2024, Loomis, Sayles & Company held 809 positions worth $79.2B, up 4% from $76.2B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Loomis, Sayles & Company's Q4 2024 filing shows 117 new, 205 increased, 335 reduced and 91 closed positions. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M. The largest sale was Tesla, an estimated $853M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $331M increase.
- Loomis, Sayles & Company's biggest Q4 2024 reduction was Tesla, cutting an estimated $853M.
- Loomis, Sayles & Company fully exited Medpace in Q4 2024, selling an estimated $68.7M.
- Loomis, Sayles & Company's ten largest holdings make up 49% of its $79.2B portfolio in Q4 2024.
- Loomis, Sayles & Company opened 117 new positions and closed 91 in Q4 2024.
- Loomis, Sayles & Company's portfolio value rose 4% quarter-over-quarter to $79.2B.
Based on Loomis, Sayles & Company's 13F filing for Q4 2024, filed 12 Feb 2025.